Literature DB >> 26890438

Rate of Gestational Diabetes Mellitus and Pregnancy Outcomes in Patients with Chronic Hypertension.

Mateo G Leon1, Hind N Moussa1, Monica Longo1, Claudia Pedroza2, Ziad A Haidar1, Hector Mendez-Figueroa1, Sean C Blackwell1, Baha M Sibai1.   

Abstract

Objective This study aims to determine the rate of gestational diabetes mellitus (GDM) in pregnancies complicated by chronic hypertension and to compare the adverse outcomes in chronic hypertensive pregnancies with and without GDM. Study Design A secondary analysis from a multicenter trial of low-dose aspirin for preeclampsia prevention in women with chronic hypertension. The rate of GDM was evaluated among singleton pregnancies complicated with chronic hypertension and grouped according to their GDM status. Pregnancy outcomes and rates of preterm delivery < 35 weeks and < 32 weeks, preeclampsia, indicated preterm birth, small for gestational age, abruptio placentae, and perinatal death were compared between those with and without GDM. A subgroup analysis comparing women who developed superimposed preeclampsia with and without GDM was studied. Multivariate logistic-regression analysis was used to adjust for potentially confounding factors. Results A total of 763 women met the inclusion criteria: 129 (17%) developed GDM. Parity, race, maternal baseline blood pressure, antihypertensive drug use, and assignment to low-dose aspirin were not significantly different between the groups with and without GDM. Using univariate analysis, maternal age (33 vs. 24%, p = 0.03) and body mass index (88 vs. 57%, p < 0.001) were higher in those who had GDM, whereas the rate of preterm delivery < 32 weeks (12 vs. 5%, p = 0.02) was higher among those without GDM. Using logistic-regression analysis, the rate of composite adverse outcomes (adjusted odds ratio [aOR], 0.77; 95% confidence interval [CI], 0.41-1.47) that included indicated preterm birth, small for gestational age, abruptio placentae, and perinatal death showed no significant differences.Superimposed preeclampsia developed in 34 (26%) women with GDM and in 182 (29%) without GDM. When superimposed preeclampsia was present, it developed at an earlier gestational age among the group without GDM (35 ± 5 vs. 37 ± 3 weeks, p = 0.003), and had higher rates of small for gestational age infants (18 vs. 3%, p = 0.03). After adjustment for confounders, only length of stay in neonatal intensive care unit was longer for those without GDM who developed superimposed preeclampsia (aOR, 0.42; 95% CI, 0.2-0.93). Conclusion Women with chronic hypertension are at a high risk for developing GDM. Outcomes in patients with chronic hypertension and GDM are not significantly different from those with chronic hypertension only. Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26890438     DOI: 10.1055/s-0036-1571318

Source DB:  PubMed          Journal:  Am J Perinatol        ISSN: 0735-1631            Impact factor:   1.862


  10 in total

1.  Maternal childhood cardiometabolic risk factors and pregnancy complications.

Authors:  Maeve Wallace; Lydia Bazzano; Wei Chen; Emily Harville
Journal:  Ann Epidemiol       Date:  2017-06-29       Impact factor: 3.797

2.  Facilitating safety evaluation in maternal immunization trials: a retrospective cohort study to assess pregnancy outcomes and events of interest in low-risk pregnancies in England.

Authors:  Megan Riley; Dimitra Lambrelli; Sophie Graham; Ouzama Henry; Andrea Sutherland; Alexander Schmidt; Nicola Sawalhi-Leckenby; Robert Donaldson; Sonia K Stoszek
Journal:  BMC Pregnancy Childbirth       Date:  2022-06-01       Impact factor: 3.105

3.  Antiplatelet agents for preventing pre-eclampsia and its complications.

Authors:  Lelia Duley; Shireen Meher; Kylie E Hunter; Anna Lene Seidler; Lisa M Askie
Journal:  Cochrane Database Syst Rev       Date:  2019-10-30

4.  Fasting glucose concentrations and associations with reproductive history over 40 years of follow-up.

Authors:  Maeve E Wallace; Lydia Bazzano; Cuilin Zhang; Emily Harville
Journal:  Gynecol Endocrinol       Date:  2018-01-24       Impact factor: 2.260

5.  Maternal and Neonatal Outcome in Mothers with Gestational Diabetes Mellitus.

Authors:  G Thiruvikrama Prakash; Ashok Kumar Das; Syed Habeebullah; Vishnu Bhat; Suryanarayana Bettadpura Shamanna
Journal:  Indian J Endocrinol Metab       Date:  2017 Nov-Dec

6.  Prevalence and Determinants of Gestational Diabetes Mellitus: A Cross-Sectional Study in China.

Authors:  Xianglong Xu; Ying Liu; Dengyuan Liu; Xiaoming Li; Yunshuang Rao; Manoj Sharma; Yong Zhao
Journal:  Int J Environ Res Public Health       Date:  2017-12-08       Impact factor: 3.390

Review 7.  Exosomes Could Offer New Options to Combat the Long-Term Complications Inflicted by Gestational Diabetes Mellitus.

Authors:  Juliana Ferreira Floriano; Gareth Willis; Francesco Catapano; Patrícia Rodrigues de Lima; Fabiana Vieira Duarte Souza Reis; Angélica Mercia Pascon Barbosa; Marilza Vieira Cunha Rudge; Costanza Emanueli
Journal:  Cells       Date:  2020-03-10       Impact factor: 6.600

8.  Prevalence of Gestational Diabetes in India by Individual Socioeconomic, Demographic, and Clinical Factors.

Authors:  Goutham Swaminathan; Akshay Swaminathan; Daniel J Corsi
Journal:  JAMA Netw Open       Date:  2020-11-02

9.  Prevalence and Predictors of Pre-Existing Hypertension among Prenatal Women: A Cross-Sectional Study in Ghana.

Authors:  Hawawu Hussein; Mansour Shamsipour; Masud Yunesian; Mohammad Sadegh Hassanvand; Abraham Assan; Akbar Fotouhi
Journal:  Iran J Public Health       Date:  2021-06       Impact factor: 1.429

Review 10.  Vascular endothelial growth factor and its receptors regulation in gestational diabetes mellitus and eclampsia.

Authors:  Alayi Bolatai; Yujing He; Na Wu
Journal:  J Transl Med       Date:  2022-09-05       Impact factor: 8.440

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.